Edgewise Therapeutics News and Activities

Edgewise Therapeutics is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Edgewise Therapeutics is a company listed under the stock ticker EWTX (US).

Acquisition, funding and merger involving Edgewise Therapeutics.

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).

View the org chart displaying its 33 main executives

Most searched biographies at Edgewise Therapeutics

• Kevin Koch, Chief Executive Officer and Director
• Badreddin Edris, Director
• Jonathan Fox, Director

Popular executive movements at Edgewise Therapeutics

• Christopher Martin has joined the company as Director  (posted on November 21 2025).
• Michael Nofi has joined the company as Chief Financial Officer  (posted on November 11 2025).
• Michael Carruthers, Chief Financial Officer, has left the company  (posted on November 11 2025).

Create your alert
to follow the executive moves at Edgewise Therapeutics.

Edgewise Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Edgewise Therapeutics

• Edgewise Theraupetics, Inc. - News

Social media about Edgewise Therapeutics

• Edgewise Therapeutics on Wikipedia, Google News & Yahoo Finance
• Edgewise Therapeutics on LinkedIn, X (Twitter) & YouTube